Gen-Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $915K | Buy |
13,251
+3,534
| +36% | +$244K | 0.35% | 77 |
|
|
2025
Q1 | $675K | Buy |
9,717
+2,218
| +30% | +$154K | 0.28% | 97 |
|
|
2024
Q4 | $645K | Buy |
7,499
+246
| +3% | +$21.2K | 0.28% | 90 |
|
|
2024
Q3 | $821K | Buy |
7,253
+1,529
| +27% | +$173K | 0.36% | 63 |
|
|
2024
Q2 | $817K | Buy |
5,724
+1,100
| +24% | +$157K | 0.39% | 57 |
|
|
2024
Q1 | $594K | Buy |
+4,624
| New | +$594K | 0.29% | 78 |
|